![(S)-2-Ethyl-8-methyl-1-thia-4,8-diazaspiro[4.5]decan-3-one structure, CAS 503431-81-0](/structures/210000/202108_3_503431_81_0.png)
CAS Number503431-81-0
Synonyms(2S)-2-Ethyl-8-methyl-1-thia-4,8-diazaspiro[4,5]decan-3-one; (2S)-2-ETHYL-8-METHYL-1-THIA-4,8-DIAZASPIRO[4,5]DECAN-3-ONE; NGX 267; 1-Thia-4,8-diazaspiro(4.5)decan-3-one,2-ethyl-8-methyl-,(2S); AF267B
Molecular FormulaC10H18N2OS
Molecular Weight214.32800
Density1.171g/cm3
Boiling Point399.167ºC at 760 mmHg
Melting Point132-134ºC
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 503431-81-0 |
| Catalog No. | 2A-2200100 |
| Chinese Name | (2S)-2-乙基-8-甲基-1-硫代-4,8-二氮杂螺[4.5]-3-癸酮 |
| Synonyms | (2S)-2-Ethyl-8-methyl-1-thia-4,8-diazaspiro[4,5]decan-3-one; (2S)-2-ETHYL-8-METHYL-1-THIA-4,8-DIAZASPIRO[4,5]DECAN-3-ONE; NGX 267; 1-Thia-4,8-diazaspiro(4.5)decan-3-one,2-ethyl-8-methyl-,(2S); AF267B |
| Molecular Formula | C10H18N2OS |
| Molecular Weight | 214.32800 |
| Density | 1.171g/cm3 |
| Boiling Point | 399.167ºC at 760 mmHg |
| Melting Point | 132-134ºC |
| Storage Condition | 2-8°C |
| HTC | 2934999090 |
| SMILES | CCC1SC2(CCN(C)CC2)NC1=O |
| InChI Key | PHOZOHFUXHPOCK-QMMMGPOBSA-N |
| Use of | NGX-267 is a muscarinic M1 agonist potentially for the treatment of Xerostomia, Alzheimer's disease and cognitive Properties Name (2S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro[4.5]decan-3-one Synonym More Synonyms Chemical & Physical Properties Molecular Formula C10H18N2OS Exact Mass 214.11400 PSA 57.64000 LogP 1.31660 Index of Refraction 1.569 InChIKey PHOZOHFUXHPOCK-QMMMGPOBSA-N SMILES CCC1SC2(CCN(C)CC2)NC1=O |
| Tax Rebate | 13.0% |
| Supervision | None. MFN tariff: 6.5%. Ordinary tariff: 20.0% |
| Transport Info | Product name: Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| Related Products in Pharmaceutical Intermediates | ||
|---|---|---|
| 1,4-dimethyl-1,4-diazabicyclo[2.2.2]octane-1,4-diium bromid | 5450-74-8 | 2A-2199935 |
| (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(3-chloro-4-hydroxyphenyl)propanoic acid | 478183-58-3 | 2A-4199968 |
| (R)-Ramelteon | 196597-27-0 | 2A-1200055 |
| (S)-2-(BENZYLOXYCARBONYLAMINO)-3-BUTENOIC ACID METHYL ESTER | 75266-40-9 | 2A-1200078 |
| 1-(4-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-N,N-dimethylmethanamine | 1198277-82-5 | 2A-2200094 |
| Benzamide, N-[(1-nitroso-2-piperidinyl)methyl]-2,5-bis(2,2,2-trifluoroethoxy)- | 2901109-58-6 | 2A-1200107 |
| (1R,2S)-(+)-BORNYLAMINE HCL | 73657-24-6 | 2A-1200110 |
| Rel-methyl (1R,2R,4R)-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylate | 17791-33-2 | 2A-2200126 |
| (S)-O-[(2,2-DIMETHYL-1,3-DIOXOLAN-4-YL)METHYL]-HYDROXYAMINE HYDROHLORIDE | 120564-14-9 | 2A-1200111 |
| (1S,2R)-FMOC-2-AMINOCYCLOHEXANE CARBOXYLIC ACID | 430460-38-1 | 2A-0200177 |
| Browse all Pharmaceutical Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA